Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Global Advertising News.
Press releases published on March 20, 2025
Cognition Therapeutics Reports Year End 2024 Financial Results and Provides Business Update
GlobeNewswire
·
March 20, 2025
Positive Results with Zervimesine (CT1812) in Phase 2 SHIMMER Dementia with Lewy Bodies (DLB) Phase 2 SHINE Data Show Dramatic Slowing of Cognitive Decline with Zervimesine in a Key Pre-specified Alzheimer’s Disease Subgroup 2025 Objective: Advance …
Sitryx initiates Phase 1 clinical trial of potential disease-modifying treatment for atopic dermatitis SYX-5219
GlobeNewswire
·
March 20, 2025
Sitryx initiates Phase 1 clinical trial of potential disease-modifying treatment for atopic dermatitis SYX-5219 SYX-5219 is a first-in-class oral PKM2 modulator designed to drive sustained disease remission Novel mechanism of action suggests SYX-5219 has …
FPO/TPO Synthetic Roofing Membrane Market is Projected USD 1,489.0 Million, Expanding at 4.4% CAGR by 2035 | Fact.MR Analysis
GlobeNewswire
·
March 20, 2025
Rockville, MD, March 20, 2025 (GLOBE NEWSWIRE) -- According to Fact.MR, a market research and competitive intelligence provider, the FPO/TPO synthetic roofing membrane market was valued at USD 928.3 million in 2024 and is expected to grow at a CAGR of 4.4% …
Axonius Unveils the Axonius Asset Cloud, a Suite of Products that Transforms Asset Intelligence into Intelligent Action
GlobeNewswire
·
March 20, 2025
DALLAS, March 20, 2025 (GLOBE NEWSWIRE) -- Axonius, the leader in cyber asset management that delivers visibility and actionability across all digital assets, today introduced the Axonius Asset Cloud, a groundbreaking suite of products designed to …
Wugen Announces Dosing of First Patients in Pivotal Trial of Off-the-Shelf, Allogeneic, CD7-Targeted CAR-T Cell Therapy WU-CART-007
GlobeNewswire
·
March 20, 2025
-- Previously reported Phase 1/2 data on WU-CART-007 demonstrated clinically manageable safety and evidence of anti-leukemic activity with an overall response rate of 91% and composite complete remission rate of 73% in heavily pretreated patients with R/R …
OTC Markets Group Welcomes QNB Corp. to OTCQX
GlobeNewswire
·
March 20, 2025
NEW YORK, March 20, 2025 (GLOBE NEWSWIRE) -- OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced QNB Corp. (OTCQX: QNBC), the holding company for QNB Bank, has qualified …
Intermap’s Insurance Business Starts 2025 With Strong Growth
GlobeNewswire
·
March 20, 2025
Year-to-date insurance awards surpass $1.1 million Two new strategic partnerships with major insurance customers DENVER, March 20, 2025 (GLOBE NEWSWIRE) -- Intermap Technologies (TSX: IMP; OTCQB: ITMSF) (“Intermap” or the “Company”), a global leader in 3D …
Avalo Reports 2024 Financial Results and Recent Business Updates
GlobeNewswire
·
March 20, 2025
Topline data from Phase 2 LOTUS Trial of AVTX-009 for the treatment of hidradenitis suppurativa expected in 2026 Appointed Jennifer Riley as Chief Strategy Officer Cash on hand of approximately $135 million as of December 31, 2024 expected to provide …
Eyenovia Enters into Non-Binding Letter of Intent to Effect Reverse Merger with Betaliq
GlobeNewswire
·
March 20, 2025
Combination, if successful, would create a new publicly-listed eye care company combining Betaliq’s EyeSol® water-free drug delivery technology for glaucoma with Eyenovia’s Optejet® device platform The combined company would continue marketing Eyenovia’s …
Plymouth Industrial REIT Expands Portfolio in Atlanta and Cincinnati
GlobeNewswire
·
March 20, 2025
BOSTON, March 20, 2025 (GLOBE NEWSWIRE) -- Plymouth Industrial REIT, Inc. (NYSE: PLYM) (the “Company”) today announced it has acquired the second tranche of the previously announced Cincinnati small bay industrial portfolio consisting of four buildings …
Baker Hughes to Provide Fully Integrated Completions for Petrobras’ Offshore Fields
GlobeNewswire
·
March 20, 2025
New solutions will support remote operations in deepwater fields Technology allows real-time response to evolving well conditions across multiple zones HOUSTON and LONDON, March 20, 2025 (GLOBE NEWSWIRE) -- Baker Hughes (NASDAQ: BKR), an energy technology …
Predictive Oncology Completes Sale of Skyline Medical Assets to DeRoyal Industries
GlobeNewswire
·
March 20, 2025
Deal positions STREAMWAY® Systems with an established market leader to drive accelerating growth Transaction allows Predictive Oncology to be highly focused on its core AI-driven drug discovery capabilities and integrate seamlessly with Renovaro …
Paramount Secures Approval from Oregon State Agencies for Proposed Technologies and Processes at Its Wholly Owned Grassy Mountain Gold Project
GlobeNewswire
·
March 20, 2025
WINNEMUCCA, Nevada, March 20, 2025 (GLOBE NEWSWIRE) -- Paramount Gold Nevada Corp. (NYSE American: PZG) (“Paramount” or the “Company”) announced today that, at a public meeting of the Technical Review Team (“TRT”), the state agencies voted unanimously to …
Immuneering Names Dr. Igor Matushansky as Chief Medical Officer
GlobeNewswire
·
March 20, 2025
Industry veteran brings extensive oncology drug development expertise and experience in clinical treatment of cancer patients Dr. Matushansky joins as Immuneering plans to present updated data from Phase 2a trial of IMM-1-104 in pancreatic cancer in Q2 …
Introducing FUJIFILM GFX100RF: The first FUJIFILM GFX System Fixed-Lens Mirrorless Digital Camera
GlobeNewswire
·
March 20, 2025
VALHALLA, N.Y., March 20, 2025 (GLOBE NEWSWIRE) -- FUJIFILM North America Corporation today announced the launch of its “FUJIFILM GFX100RF” (GFX100RF) mirrorless digital camera. GFX100RF is the first digital camera with a fixed lens in the history of the …
Autolus Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Business Updates
GlobeNewswire
·
March 20, 2025
AUCATZYL® (obecabtagene autoleucel) U.S. commercial launch progressing on track with 33 authorized treatment centers as of March 19, 2025, following US FDA approval on November 8, 2024 Obe-cel MHRA and EMA marketing authorizations expected in H2 2025 …
British King Gold Project: Filing of NI43-101 Technical Report
GlobeNewswire
·
March 20, 2025
VANCOUVER, British Columbia, March 20, 2025 (GLOBE NEWSWIRE) -- Central Iron Ore Limited. (CIO – TSX.V) (“CIO” or “the Company”) is pleased to announce that is has filed a National Instrument 43-101 Technical Report Mineral Resource Estimate, British King …
Destination XL Group, Inc. Reports Fiscal 2024 Fourth Quarter and Full-Year Financial Results
GlobeNewswire
·
March 20, 2025
CANTON, Mass., March 20, 2025 (GLOBE NEWSWIRE) -- Destination XL Group, Inc. (NASDAQ: DXLG), the largest integrated commerce specialty retailer of Big + Tall men’s clothing and shoes, today reported financial results for the fourth quarter and fiscal year …
ARS Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Updates
GlobeNewswire
·
March 20, 2025
$7.3 million in total neffy® (epinephrine nasal spray) U.S. net product revenue in 2024 since launch in late September 2024 neffy 1 mg approved by U.S. FDA for children aged four and older and weighing 15 kilograms to < 30 kilograms (33 lbs. to < 66 lbs.), …
Enthusiast Gaming’s Addicting Games Partners with ByteBrew to Provide Enhanced Analytics for its Web Game Developers
GlobeNewswire
·
March 20, 2025
LOS ANGELES, March 20, 2025 (GLOBE NEWSWIRE) -- Enthusiast Gaming Holdings Inc. (“Enthusiast Gaming” or the “Company”) (TSX: EGLX), a leading gaming media and entertainment company, announced a strategic partnership between its web-based gaming platform, …